In vitro binding assessment andin vivo efficacy of several adsorbents against aflatoxin B1

Abstract

Aflatoxins are a class of mycotoxins that impair poultry health and performance. Some clays have the ability to adsorb aflatoxins. In our study, mineralogical composition of the tested clays was confirmed by powder X-ray diffraction and simultaneous thermal analysis and their properties like pH, electrical conductivity, exchangeable cations, cation exchange capacity and clay content were determined. For theirin vitro assessment regarding aflatoxin B1 (AFB1) adsorption, adsorption tests under ‘intensified conditions’ (low adsorbent and high toxin concentration) were carried out in buffers at various pH values and in real gastric juice followed by isothermal analysis in phosphate buffer.In vivo we used a completely randomised design with 4 replicate pens of 5 chicks assigned to each dietary treatment from hatch to 21 days. Dietary treatments included a negative and a positive control diet (2 mg/kg AFB1), and treatment groups receiving 2 mg/kg AFB1 and 0.5% of one of 8 adsorbents. Results ofin vitro experiments ranked the adsorbents as ‘good’ (R, MB, B7, M32, M34, M5; 6 bentonites containing acis-vacant smectite), ‘average’ (bentonite C2 containing atrans-vacant smectite) or ‘poor’ (zeolite Z08, containing clinoptilolite). The addition of AFB1 significantly reduced feed intake and/or body weight gain of the chicks compared to the negative control and to the treatment groups, except for C2 and Z08. Except Z08, all adsorbents numerically decreased the liver weight compared to the AFB1-fed group. Kidney weights were significantly increased by the addition of AFB1 compared to the control and most adsorbents, except C2 and Z08. Similarly, ‘good’ adsorbents significantly prevented the decrease in serum albumin and serum total protein. The ability of adsorbents to ameliorate AFB1 toxicity in poultry basically correlated with thein vitro findings meaning that ‘poor’ and ‘average’ adsorbents did not (Z08) or only partially (C2) protect against AFB1 in vivo.